|
US3451062A
(en)
*
|
1966-03-16 |
1969-06-24 |
Theodore Bradley |
Disposable examination gown
|
|
GB1140748A
(en)
*
|
1966-06-23 |
1969-01-22 |
Ici Ltd |
New carboxylic acid derivatives
|
|
US3658967A
(en)
*
|
1966-06-23 |
1972-04-25 |
Ici Ltd |
Carboxylic acid derivatives for lowering the concentration of triglycerides in the blood
|
|
CH480308A
(de)
*
|
1966-08-11 |
1969-10-31 |
Ciba Geigy |
Verfahren zur Herstellung von Thiosemicarbazid-Verbindungen
|
|
US4049663A
(en)
*
|
1972-06-06 |
1977-09-20 |
Allen & Hanburys Limited |
Ethylene diamine derivatives
|
|
US4087544A
(en)
*
|
1974-12-21 |
1978-05-02 |
Warner-Lambert Company |
Treatment of cranial dysfunctions using novel cyclic amino acids
|
|
DE2460891C2
(de)
*
|
1974-12-21 |
1982-09-23 |
Gödecke AG, 1000 Berlin |
1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
US4311853A
(en)
*
|
1979-02-06 |
1982-01-19 |
The Radiochemical Centre Limited |
Selenium derivatives of thyroxine and tri-iodothyronine
|
|
DE3010599A1
(de)
*
|
1979-03-22 |
1980-10-09 |
Continental Pharma |
Derivate von glycinamid, deren herstellung und verwendung
|
|
US4267354A
(en)
*
|
1979-04-25 |
1981-05-12 |
E. R. Squibb & Sons, Inc. |
Substituted amides having antiinflammatory activity and intermediates
|
|
DD151309A5
(de)
*
|
1979-06-01 |
1981-10-14 |
Wellcome Found |
Verfahren zur herstellung von substituierten aminotriazinen
|
|
FR2480747A1
(fr)
*
|
1980-04-17 |
1981-10-23 |
Roques Bernard |
Derives d'acides amines et leur application therapeutique
|
|
DE3483308D1
(de)
*
|
1983-11-21 |
1990-10-31 |
Fujisawa Pharmaceutical Co |
Semicarbazid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
|
|
US4631287A
(en)
*
|
1985-04-16 |
1986-12-23 |
Usv Pharmaceutical Corp. |
Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
|
|
US4839369A
(en)
*
|
1985-04-16 |
1989-06-13 |
Rorer Pharmaceutical Corporation |
Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
|
|
US4725619A
(en)
*
|
1985-04-16 |
1988-02-16 |
Usv Pharmaceutical Corporation |
Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
|
|
GB8714901D0
(en)
*
|
1986-07-23 |
1987-07-29 |
Ici Plc |
Amide derivatives
|
|
GB2216515A
(en)
*
|
1988-03-04 |
1989-10-11 |
Nippon Shinyaku Co Ltd |
Acylphenol derivatives
|
|
RU2070041C1
(ru)
*
|
1988-03-04 |
1996-12-10 |
Киргизский государственный медицинский институт |
Средство для стимуляции лейкопоэза
|
|
US4894476A
(en)
*
|
1988-05-02 |
1990-01-16 |
Warner-Lambert Company |
Gabapentin monohydrate and a process for producing the same
|
|
FR2639225B1
(fr)
*
|
1988-11-21 |
1993-05-21 |
Centre Nat Rech Scient |
Compositions pharmaceutiques pour la neuroprotection contenant des arylcyclohexylamines
|
|
IL94466A
(en)
*
|
1989-05-25 |
1995-01-24 |
Erba Carlo Spa |
Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
|
|
US5051403A
(en)
*
|
1989-11-22 |
1991-09-24 |
Neurex Corporation |
Method of treating ischemia-related neuronal damage
|
|
US5025035A
(en)
*
|
1990-10-12 |
1991-06-18 |
Warner-Lambert Company |
Method of treating depression
|
|
SG50624A1
(en)
*
|
1991-12-30 |
1998-07-20 |
Neurex Corp |
Methods of producing analgesia and enhancing opiate analgesia
|
|
GB9203483D0
(en)
*
|
1992-02-19 |
1992-04-08 |
Wellcome Found |
Anti-inflammatory compounds
|
|
US5330515A
(en)
*
|
1992-06-17 |
1994-07-19 |
Cyberonics, Inc. |
Treatment of pain by vagal afferent stimulation
|
|
US5256669A
(en)
*
|
1992-08-07 |
1993-10-26 |
Aminotek Sciences, Inc. |
Methods and compositions for treating acute or chronic pain and drug addiction
|
|
US5498610A
(en)
*
|
1992-11-06 |
1996-03-12 |
Pfizer Inc. |
Neuroprotective indolone and related derivatives
|
|
GB9306886D0
(en)
*
|
1993-04-01 |
1993-05-26 |
Erba Carlo Spa |
Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
|
|
GB9306899D0
(en)
*
|
1993-04-01 |
1993-05-26 |
Erba Carlo Spa |
Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
|
|
US5475007A
(en)
*
|
1993-05-28 |
1995-12-12 |
The Regents Of The University Of California |
1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and the use thereof
|
|
ZA953078B
(en)
*
|
1994-04-28 |
1996-01-05 |
Alza Corp |
Effective therapy for epilepsies
|
|
US5482964A
(en)
*
|
1994-10-11 |
1996-01-09 |
Warner-Lambert Company |
Substituted phenoxyhydroxypropyl amines as central nervous system agents
|
|
US5541204A
(en)
*
|
1994-12-02 |
1996-07-30 |
Bristol-Myers Squibb Company |
Aryloxypropanolamine β 3 adrenergic agonists
|
|
GB9426102D0
(en)
*
|
1994-12-23 |
1995-02-22 |
Merck Sharp & Dohme |
Pharmacuetical compositions
|
|
KR0147963B1
(ko)
*
|
1995-01-10 |
1998-08-17 |
강박광 |
엔-아릴알킬페닐아세트아미드 유도체와 그의 제조방법
|
|
GB9500691D0
(en)
*
|
1995-01-13 |
1995-03-08 |
Smithkline Beecham Plc |
Compounds
|
|
US5849737A
(en)
*
|
1995-04-14 |
1998-12-15 |
The Regents Of The University Of California |
Compositions and methods for treating pain
|
|
US5741818A
(en)
*
|
1995-06-07 |
1998-04-21 |
University Of Saskatchewan |
Semicarbazones having CNS activity and pharmaceutical preparations containing same
|
|
GB9512854D0
(en)
*
|
1995-06-23 |
1995-08-23 |
Wellcome Found |
Novel formulation
|
|
US5795864A
(en)
*
|
1995-06-27 |
1998-08-18 |
Neurex Corporation |
Stable omega conopetide formulations
|
|
GB9515412D0
(en)
*
|
1995-07-27 |
1995-09-27 |
Pharmacia Spa |
2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
|
|
US5688830A
(en)
*
|
1996-01-25 |
1997-11-18 |
Syntex (U.S.A.) Inc. |
Treatment of neuropathic pain
|
|
US6372792B1
(en)
*
|
1996-04-26 |
2002-04-16 |
Guy Chouinard |
Method for treating anxiety, anxiety disorders and insomnia
|
|
CA2264182A1
(en)
*
|
1996-08-23 |
1998-02-26 |
Algos Pharmaceutical Corporation |
Anticonvulsant containing composition for treating neuropathic pain
|
|
US6290986B1
(en)
*
|
1996-10-24 |
2001-09-18 |
Pharmaceutical Applications Associates, Llc |
Method and composition for transdermal administration of pharmacologic agents
|
|
US6207685B1
(en)
*
|
1996-12-06 |
2001-03-27 |
Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) |
Therapeutic application of a thienycyclohexylamine derivative
|
|
US6117841A
(en)
*
|
1997-05-30 |
2000-09-12 |
Warner-Lambert Company |
Substituted peptidylamine calcium channel blockers
|
|
WO1999008670A1
(en)
*
|
1997-08-20 |
1999-02-25 |
Guglietta, Antonio |
Gaba analogs to prevent and treat gastrointestinal damage
|
|
IT1295423B1
(it)
*
|
1997-10-10 |
1999-05-12 |
Medivis S R L |
Uso della flunarizina nella terapia topica del glaucoma
|
|
EP2201945B1
(en)
*
|
1997-11-21 |
2013-03-06 |
Purdue Neuroscience Company |
Use of substituted 2-aminoacetamides for treating or ameliorating anxiety
|
|
GB9727523D0
(en)
*
|
1997-12-31 |
1998-02-25 |
Pharmacia & Upjohn Spa |
Alpha-aminoamide derivatives useful as analgesic agents
|
|
GB9727521D0
(en)
*
|
1997-12-31 |
1998-02-25 |
Pharmacia & Upjohn Spa |
Substituted 2-benzylamino-2-phenyl-acetamide compounds
|
|
US5905069A
(en)
*
|
1998-01-26 |
1999-05-18 |
The General Hospital Corporation |
Methods of decreasing or preventing pain using spicamycin or derivatives thereof
|
|
US6458781B1
(en)
*
|
1998-04-27 |
2002-10-01 |
David Thomas Connor |
Substituted diarylalkyl amides as calcium channel antagonists
|
|
SE9801494D0
(sv)
*
|
1998-04-28 |
1998-04-28 |
Astra Pharma Prod |
Novel use
|
|
US6011035A
(en)
*
|
1998-06-30 |
2000-01-04 |
Neuromed Technologies Inc. |
Calcium channel blockers
|
|
EP1094817A1
(en)
*
|
1998-07-09 |
2001-05-02 |
Warner-Lambert Company |
Compositions comprising gaba analogs and caffeine
|
|
WO2000006559A1
(en)
*
|
1998-07-30 |
2000-02-10 |
Warner-Lambert Company |
Reduced dipeptide analogues as calcium channel antagonists
|
|
US6281211B1
(en)
*
|
1999-02-04 |
2001-08-28 |
Euro-Celtique S.A. |
Substituted semicarbazides and the use thereof
|
|
NZ527771A
(en)
*
|
1999-08-04 |
2005-04-29 |
Icagen Inc |
Methods for treating or preventing anxiety
|
|
US6472530B1
(en)
*
|
1999-09-22 |
2002-10-29 |
Ortho-Mcneil Pharmaceutical, Inc. |
Benzo-fused dithiepino[6,5-b]pyridines, and related compositions and methods
|
|
US6113915A
(en)
*
|
1999-10-12 |
2000-09-05 |
Allergan Sales, Inc. |
Methods for treating pain
|
|
JP2003528104A
(ja)
*
|
2000-03-23 |
2003-09-24 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
チエピノ［３，２−ｂ］ジヒドロピリジンおよび関連組成物ならびに方法
|
|
US6521647B2
(en)
*
|
2000-04-04 |
2003-02-18 |
Pfizer Inc. |
Treatment of renal disorders
|
|
IL160523A0
(en)
*
|
2001-09-03 |
2004-07-25 |
Newron Pharm Spa |
PHARMACEUTICAL COMPOSITION COMPRISING GABAPENTIN OR AN ANALOGUE THEREOF AND AN alpha-AMINOAMIDE AND ITS ANALGESIC USE
|
|
EP1458386B1
(en)
*
|
2001-12-27 |
2007-04-18 |
Ortho-McNeil Pharmaceutical, Inc. |
Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder
|
|
EP1438956A1
(en)
*
|
2003-01-16 |
2004-07-21 |
Newron Pharmaceuticals S.p.A. |
Alpha-aminoamide derivatives useful as antimigraine agents
|
|
US20040213842A1
(en)
*
|
2003-01-30 |
2004-10-28 |
Dynogen Pharmaceuticals, Inc. |
Methods of treating gastrointestinal tract disorders using sodium channel modulators
|
|
EP1589959A2
(en)
*
|
2003-01-30 |
2005-11-02 |
Dynogen Pharmaceuticals Inc. |
Methods of treating lower urinary tract disorders using sodium channel modulators
|
|
AR044007A1
(es)
*
|
2003-04-11 |
2005-08-24 |
Newron Pharmaceuticals Inc |
Metodos para el tratamiento de la enfermedad de parkinson
|
|
AU2004266494B2
(en)
*
|
2003-08-25 |
2010-04-08 |
Newron Pharmaceuticals, Spa |
Alpha-aminoamide derivatives useful as anti-inflammatory agents
|
|
EP1535908A1
(en)
*
|
2003-11-24 |
2005-06-01 |
Newron Pharmaceuticals S.p.A. |
N-acyl-N'-benzyl-alkylendiamino drivatives
|
|
EP1557166A1
(en)
*
|
2004-01-21 |
2005-07-27 |
Newron Pharmaceuticals S.p.A. |
Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
|
|
EP1588704A1
(en)
*
|
2004-04-22 |
2005-10-26 |
Newron Pharmaceuticals S.p.A. |
Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
|
|
ATE471147T1
(de)
*
|
2004-09-10 |
2010-07-15 |
Newron Pharm Spa |
Verwendung von (r)-(halogenbenzyloxy)-benzylamino-propanamiden als natrium- und/oder calciumkanal- selektive modulatoren
|